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Abstract
Objectives
Breast cancer (BC) is prevalent in low and middle-income countries (LMICs) where the
majority of cases are diagnosed in late stages. The aims of this study were: (1) to assess
quality of life (QOL) and health status of Indonesian women with BC symptoms before defin-
itive diagnosis; (2) to compare QOL and health status between women with BC symptoms
before definitive diagnosis and Indonesian women in general; (3) to evaluate the association
between demographic variables (age, residence, social economic status and education
level) and QOL within the Indonesian women with BC symptoms before definitive diagnosis.
Methods
We used WHOQOL-BREF to measure QOL and EQ-5D-5L for health status. Multivariate
analysis of covariance (MANCOVA) was used to compare QOL and health status between
women with BC symptoms and women from the general Indonesian population in order to
control for confounders. Regression analyses were used for testing the association between
the demographic variables, QOL, and health status.
Results
In comparison with the data from the women from the general population (n = 471), the
women with BC symptoms (n = 132) reported lower QOL, especially in physical and psycho-
logical domains. They also reported more problems in all dimensions of health status.
Higher education and monthly income were positively associated with QOL and health sta-
tus among the women with BC symptoms.
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Conclusion
Before receiving a definitive diagnosis, women who visit hospitals with symptoms of BC,
report a lower QOL and health status than women in general. Our results suggest that
healthcare providers should provide targeted strategies for women with BC symptoms to
improve their QOL.
Introduction
Breast cancer (BC) is the most frequently diagnosed malignant tumor among women in both
high-income countries (HICs) and low and middle-income countries (LMICs) [1]. The inci-
dence of BC in LMICs is lower than for HICs, but mortality rates in LMICs are higher than in
HICs because of advanced-staged diagnosis and inadequate access to care [2]. The mortality
rates have been decreasing in many HICs since around 1990 due to early detection and
improved treatment [2]. In Indonesia, BC continues to be the most common malignancy in
women with an incidence rate of 40.3 percent and a mortality rate of 16.6 percent per 100,000
people [3].
The diagnostic process of BC and its treatments are often associated with negative effects
that can lead to lower quality of life (QOL) [4, 5]. Consequently, the current intervention of
BC should not only focus on illness control but also to maintain and improve QOL of women
with BC. Throughout the process of hospital care, from diagnosis to treatment, the BC exami-
nations and treatments affect the physical, psychological and social aspects of the life of a
woman, which can significantly reduce her QOL, increase psychological distress [6], and
uncertainty [7], negatively affect her body image and sexuality [8], illness perception [9], and
increase unmet health needs [10]. Therefore, the information about QOL is crucial at every
stage of the BC trajectory. However, most investigations explore various issues after definitive
diagnosis, e.g., QOL in women with BC during treatment [9, 11, 12] and QOL in BC survivors
[13–15].
To our knowledge, no previous investigation was conducted among the women before the
definitive diagnosis in Indonesian women. This stage is essential because some psychosocial
problems might already occur when women find abnormalities in their breasts. One of the
issues may be the uncertainty about having or not having the disease and the future treatment
process. The diagnosis of BC may have many consequences, not only related to life expectancy
but also to QOL. Some women with BC in Indonesia have a belief that BC is an incurable and
deadly disease [16]. On the other hand, despite having discovered the symptoms of BC, some
women may assume that they have no severe health problems. Given the interrelation between
demographic characteristics, QOL and health status in general [17–20], we also evaluated
which demographic attributes might contribute to a lower QOL and health status in the
women with BC symptoms.
No studies have yet been published that compared QOL and health status between undiag-
nosed women with BC symptoms and women in the general population in Indonesia. There-
fore, the aims of this study were: (1) to assess QOL and health status of Indonesian women
with BC symptoms before receiving a definitive diagnosis; (2) to compare QOL and health sta-
tus between women with BC symptoms and Indonesian women in general; (3) to evaluate the
association of socio-demographic factors with QOL and health status of Indonesian women
with BC symptoms before the definitive diagnosis. The current study that investigated QoL
and health status for women with BC symptoms before definite diagnosis may serve as a bridge
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for future studies to explore whether psychosocial concerns such as impaired body image and
unmet needs should be taken into account for women with BC symptoms before definitive
diagnosis.
Methods
Participants
This study consisted of two groups of participants: 1) Indonesian women with BC symptoms
who already consulted the hospital but yet without a definitive diagnosis (BC Symptoms
Group) and (2) Indonesian women from the general population (General Population Group).
BC symptoms group. Participants were recruited from four district hospitals in West
Java, Indonesia. They were new patients (outpatients) who visit the hospital with breast symp-
toms, which make them suspects of having BC, but yet without a definitive diagnosis. The fol-
lowing inclusion criteria were used: women with age 18 years and above, an adequate
command of the Indonesian language (Bahasa Indonesia) and no major psychiatric disorder.
The last criterion was determined by checking the medical record on a consultation history/
record with the Psychiatric Department. Patients who have been seen by a psychiatrist were
excluded from the study.
General population group. The data of the comparison group (which will be referred to
as "general population" in this manuscript) were women selected from a larger study focused
upon the Indonesian general population, in which several questionnaires were tested in a face-
to-face setting at the home/office of the interviewer or at the homes of the subjects [21].This
study implemented a multi-stage stratified quota sampling method to ensure representative-
ness with the Indonesian general population, which resulted in 1054 participants being inter-
viewed. Only the female participants with the age of 18 years and above from the
aforementioned study were included in the analysis of the present study.
Instruments
A standard socio-demographic questionnaire was used to collect participants’ background
data on residence, age, education level and income level.
QOL was measured using the Indonesian version of the WHOQOL-BREF, with a four
weeks-time retrospection. WHOQOL-BREF has been utilized in several investigations in the
BC populations in Asian countries [22], including Indonesia [9]. This instrument is a self-
report questionnaire that consists of 26 items. The internal consistency of the WHOQOL
BREF’s domains in the present sample were 0.70, 0.78, 0.57, and 0.75 for physical, psychologi-
cal, social, and environmental domain respectively. Two items measure QOL and health satis-
faction in general. Twenty-four items measure four broad domains: (i) physical health (7
items), e.g., "Do you have enough energy for everyday life?”, (ii) psychological health (6 items),
e.g., "How much do you enjoy life?”, (iii) social relationships (3 items), e.g., "How satisfied are
you with your personal relationships?” and (iv) environmental (8 items), e.g., "How satisfied
are you with the conditions of your living place?” Each item is rated using a 5-point Likert
scale with varied wording on each scale depending on the item (for example 1 = very dissatis-
fied to 5 = very satisfied) [23]. The internal consistency of the WHOQOL BREF domains in
the present sample were 0.70, 0.78, 0.57, and 0.75 for physical, psychological, social, and envi-
ronmental domain respectively.
The health status of the participants was measured by the EQ-5D-5L [24]. This instrument
has been used in several BC patient populations around the world [25]. EQ-5D-5L is a generic
health-related QOL instrument based on a descriptive system that defines health in terms of
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five dimensions: mobility (MO), self-care (SC), usual activities (UA), pain/discomfort (PD),
and anxiety/depression (AD).
Each dimension has five levels: (1) no problems, (2) slight problems, (3) moderate prob-
lems, (4) severe problems, and (5) extreme problems/unable. Therefore, the EQ-5D-5L instru-
ment describes 3125 (55) unique health states. A 1-digit number expresses the level selected for
that specific dimension. A specific health state then consisted of a combination of a 5-digit
number for the five dimensions. For example, state ‘11111’ indicates ‘no problems on any of
the five dimensions’, while state ‘34512’ indicates ‘moderate problems in walking about, severe
problems washing or dressing, extreme problems doing usual activities, no pain or discomfort,
and slight anxiety or depression’. This descriptive system is followed by a self-rating of overall
health status on a visual analogue scale (EQ-VAS) ranging from 0 ("the worst health you can
imagine") to 100 ("the best health you can imagine"). EQ-5D-5L has been proven as a valid and
reliable questionnaire to be used in Indonesia [26].
Data collection procedures
BC symptoms group. The study was approved by the Health Research Ethics Committee
of Dr. Hasan Sadikin General Hospital Bandung. Participants who agreed to participate by
means of oral or written consent were asked to complete the following instruments in the hos-
pital: (1) the socio-demographic and medical history form, (2) the WHOQOL-BREF, and (3)
the EQ-5D-5L. If they had difficulties in completing the instruments, the interviewers helped
them by reading the items out loud and asking the participants to indicate the answers.
General population group. The study was approved by the Health Research Ethics Com-
mittee, Faculty of Medicine, Universitas Padjadjaran, Indonesia [21]. A representative sample
from the Indonesian general population was recruited using multi-stage stratified quota sam-
pling. The interviewers explained the objectives of the study, followed by filling in the
informed consent when the participants agreed to participate. Three instruments completed
by the participants were: (1) the socio-demographic form: age, sex, income, and education, (2)
the WHOQOL-BREF, (3) the EQ-5D-5L. The participants were helped by the interviewers
whenever they had problems completing the questionnaires.
Data analysis
Demographic characteristics were summarized using descriptive statistics, including percent-
ages for categorical data, and means and standard deviations for continuous data. The self-
reported health problems obtained from the EQ-5D-5L were presented in percentages of each
level of each dimension that was answered positively and then compared between the groups
with the Chi-square test. Each participant’s EQ-5D-5L responses then were transformed to a
single index score based on the preference of the Indonesian general population, a so-called
‘value set’[21]. For instance, the health state of ‘11111’ corresponds to an EQ-5D-5L index
score of 1.00, and ‘22211’, which means ‘slight problems in mobility, self-care and usual activi-
ties and no problems in pain/discomfort and anxiety/depression’ leads to a value of 0.69. Mean
and standard deviation were calculated for the EQ-VAS, EQ-5D-5L index score and each
domain of the WHOQOL-BREF.
For the comparison of the QOL between the two groups, we applied an independent t-test
if the data were normally distributed or the Wilcoxon rank-sum test if not normally distrib-
uted. Normality was tested using the Shapiro-Wilk test and visual inspection of the histograms.
For determining the magnitude of the differences, we calculated the effect size using Cohen’s
d, and we applied the criteria from Cohen for the interpretation: 0.2–0.5 = small, 0.5–
0.8 = medium, >0.8 = large difference [27].
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We also applied multivariate analysis of covariance (MANCOVA) with the QOL (WHO-
QOL-BREF: physical, psychological, social, and environment domain scores) and health status
(EQ-5D-5L: EQ-VAS and index score) scores as outcomes and a variable ‘group’ (BC symp-
toms group vs. general population group) as the predictor in the MANCOVA. Further multi-
ple linear regression analysis was carried out to evaluate whether and if so which socio-
demographic variables were significantly affect the QOL and health status scores in the BC
symptom group only. Beforehand, a Spearman correlation analysis was done to check whether
any significant correlation(s) between each sociodemographic variable with other demo-
graphic variables and the outcomes (QOL and health status). We found that ethnicity and reli-
gion had no significant correlation to any other variables, therefore they were excluded from
the analysis. The following sociodemographic variables: residence (urban/rural), age, level of
education (basic: primary school and below/middle: high school/high: all others), and monthly
income (below 2 million IDR/2-4 million IDR/above 4 million IDR) were included in the mul-
tiple linear regression analysis. Statistical analyses were performed using SPSS-IBM version 21;
p-values < .05 were considered statistically significant.
Results
Characteristics of participants
The demographic characteristics of women with BC symptoms and the general population are
presented in Table 1. The proportion of age and residence subgroups were similar between the
two groups. The BC symptom group had a significantly higher level of education and monthly
income than the general population group.
QoL and health status in BC symptoms group and general population
group
The mean scores of the QOL domains: measured by the WHOQOL-BREF and health status:
measured by the EQ-5D-5L are summarized in Table 2. Concerning the QOL, the BC
Table 1. Demographic characteristics of the Breast Cancer (BC) symptoms sample (N = 132) and the general population sample (N = 471).
Characteristic Level BC Symptom General Populationa Pearson’s χ2 (df) P-value
N (%) N (%)
Age 18–30 years 48 (36.4) 157 (33.3) 0.4263 (2) 0.808
31–50 years 58 (43.9) 218 (46.3)
> 50 years 26 (19.7) 96 (20.4)
Residence Rural 74 (56.1) 217 (46.1) 4.1196 (1) 0.042
Urban 58 (43.9) 254 (53.9)
Level of Educationb Basic 22 (16.7) 172 (36.5) 18.9003 (2) <0.001
Middle 79 (59.8) 222 (47.1)
High 31 (23.5) 77 (16.3)
Income/monthc Low 60 (45.5) 403 (85.6) 93.2667 (2) <0.001
Middle 54 (40.9) 49 (10.4)
High 18 (13.6) 19 (4.0)
abased on study Purba, et al., 2017
bBasic: primary school and below, Middle: high school, High: all others
cLow:2 million IDR, Middle: 2–4 million IDR, High: above 4 million IDR
https://doi.org/10.1371/journal.pone.0200966.t001
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symptoms group showed significantly lower scores (less favorable) on physical and psychologi-
cal domains than the general population. The effect sizes for these differences were considered
as small. For health status, the EQ-VAS and index score of women with BC symptoms were
significantly lower than the general population with medium effect sizes for both scores.
Table 3 presents the comparison of the EQ-5D-5L self-reported health status of the BC
symptom and the general population samples. The proportions of responses for each severity
level of problems were significantly different for all dimensions between the two samples. It
can be seen that the percentage of the BC symptoms group which reported no problems in
four dimensions: self-care, usual activity, pain/discomfort and anxiety/depression was lower
than that of the general population. In addition, no participants from the general population
group reported the worst level of problems in any dimensions, while 1.5%, 3.8%, and 6.8% of
the BC symptoms group indicated unable/severe problems in usual activity, pain/discomfort,
and anxiety/depression, respectively.
For the MANCOVA analysis, we included the educational level and monthly income as
covariates because only these two characteristics differed significantly between the two groups.
The results still showed significant overall differences in the QOL between women with BC
symptoms and the general population (Wilks’ lambda of 0.85; p-value<0.001). A MANCOVA
conducted on the health status yielded similar results (Wilks’ lambda of 0.82; p-value<0.001).
Further multiple linear regression analysis conducted only in the BC symptoms group
showed that participants who lived in a rural area demonstrated higher social domain scores
than they who did not live in a rural area. Concerning education, participants with the lowest
educational levels (i.e. primary school and below) demonstrated lower scores (less favorable)
Table 2. Comparison of means of quality of life (QOL) and health status of the Breast Cancer (BC) symptoms and the general population sample.
BC symptom General population t-statistica P-value Effect Sizeb
Aspect Dimension Mean SD Mean SD
Quality of life Physical health 63.2 13.9 67.9 11.3 4.004 <0.001 0.4
Psychological health 62.5 15.7 65.2 12.4 2.042 0.042 0.2
Social relations 62.8 14.4 62.0 13.5 -0.609 0.543 -0.1
Environment 59.3 12.6 58.4 12.9 -0.729 0.467 -0.1
Health status EQ-VAS 69.1 20.0 78.6 14.7 6.010 <0.001 0.6
Index score 0.8 0.2 0.9 0.1 9.066 <0.001 0.9
aall degress of freedom (df) = 601
bEffect size based on Cohen’s d
https://doi.org/10.1371/journal.pone.0200966.t002
Table 3. Comparison of proportions of the EQ-5D-5L self-reported health status of the Breast Cancer (BC) symptoms sample with the general population sample.
Level of
problems
Mobility Self-Care Usual Activity Pain/Discomfort Anxiety/Depression
BC GP χ2 (df);
P-value
BC GP χ2 (df);
P-value
BC GP χ2 (df);
P-value
BC GP χ2 (df);
P-value
BC GP χ2 (df);
P-value
No 90.9 89.0 11.95 (3);
0.008
92.4 98.0 13.20 (3);
0.004
78.0 86.7 20.88 (4);
<0.001
27.3 57.3 62.95 (4);
<0.001
18.2 63.3 147.19 (4);
<0.001Slight 3.8 9.2 3.8 1.5 13.6 11.5 51.5 38.5 47.7 29.8
Moderate 3.0 1.5 3.0 0.2 5.3 1.7 13.6 3.1 15.9 6.5
Severe 2.3 0.2 0.8 0.2 1.5 0.0 3.8 1.2 11.4 0.4
Unable/ Extreme 0.0 0.0 0.0 0.0 1.5 0.0 3.8 0.0 6.8 0.0
BC = breast cancer symptom; GP = general population
https://doi.org/10.1371/journal.pone.0200966.t003
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on physical, social, and environmental QOL domains than participants who had college/uni-
versity level of education, while only physical health scores were significantly different between
the middle and the lowest levels of education. Participants in the lowest monthly income
group demonstrated less favorable scores in physical, psychological, and environment QOL
domains than participants in the highest monthly income group, while only the social domain
score was significantly different between the middle and lowest-income groups. With respect
to health status (EQ-5D-5L), participants who had the lowest educational level demonstrated
significantly lower EQ-5D-5L index scores than participants who achieved higher educational
level. We found that age had no significant association with QOL and health status of women
with BC symptoms. Details can be seen in Table 4.
Discussion
To our knowledge, this is the first study that compared the QOL between Indonesian women
with BC symptoms before the definitive diagnosis and Indonesian women in general. We
found that the QOL of Indonesian women with BC symptoms was significantly lower than in
the general Indonesian population, especially in the physical and psychological domain. They
also reported more problems across all dimensions, namely mobility, self-care, usual activity,
pain/discomfort and anxiety/depression. These findings were also maintained after correction
for demographic differences. In addition, we found that education and monthly income were
positively associated with the QOL and health status among the women with BC symptoms.
Previous studies among patients with BC reported that pain/discomfort and anxiety/
depression are the most common symptoms reported. This might be associated with lower
level of HRQOL among patients across different states of BC: after primary BC, during recur-
rence, and metastases [28–30]. Our study extended these previous results by adding that in the
phase of pre-definite diagnosis, the similar results occurred: a higher percentage of reported
problems in pain/discomfort and anxiety/depression. Note that because of the EQ-5D wording
in the two aforementioned dimensions, we don’t know yet whether the women felt pain or
Table 4. Coefficients (B-values) from multiple linear regression analysis for quality of life and health status in women with Breast Cancer (BC) symptoms.
Predictors Physical QOL Psychological QOL Social QOL Environmental QOL EQ-VAS Index score
Coeff SE P-value Coeff SE P-value Coeff SE P-value Coeff SE P-value Coeff SE P-value Coeff SE P-value
Groupa
BC -6.7 1.3 0.000 -4.8 1.4 0.001 -1.8 1.5 0.205 -2.0 1.3 0.141 -11.2 1.7 0.000 -0.2 0.0 0.000
Residenceb
Urban 0.0 0.0 0.389 0.0 0.0 0.970 -0.1 0.0 0.139 0.0 0.0 0.695 -0.1 0.1 0.084 0.0 0.0 0.001
Age -1.1 1.0 0.268 -2.2 1.1 0.041 -2.7 1.1 0.017 -1.3 1.0 0.198 -3.0 1.3 0.025 0.0 0.0 0.206
Educationc
Middle 1.8 1.1 0.109 2.1 1.2 0.091 2.4 1.3 0.065 2.5 1.2 0.034 0.4 1.5 0.777 0.0 0.0 0.051
High 2.6 1.6 0.098 4.7 1.8 0.008 5.4 1.8 0.003 6.6 1.7 0.000 4.0 2.1 0.059 0.0 0.0 0.097
Incomed
Middle 2.5 1.5 0.084 2.0 1.6 0.223 3.8 1.7 0.022 3.6 1.5 0.020 1.9 2.0 0.345 0.0 0.0 0.027
High 7.5 2.2 0.001 7.0 2.4 0.004 5.8 2.5 0.021 9.2 2.3 0.000 5.3 3.0 0.074 0.1 0.0 0.044
Constant 67.8 1.8 0.000 64.2 2.0 0.000 63.2 2.1 0.000 56.7 1.9 0.000 82.3 2.5 0.000 0.9 0.0 0.000
aGeneral population is the reference
bRural is the reference group
cBasic education level: primary school and below is the reference group
dLow monthly income is the reference group
https://doi.org/10.1371/journal.pone.0200966.t004
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discomfort and anxiety or depression. Further explorations might be needed to investigate
whether participants have problems on only one or both conditions, e.g. pain or discomfort.
Concerning the group of women with BC symptoms, we found that higher levels of educa-
tion and income were associated with more favorable physical, social, and environmental
dimensions of QOL compared to those with lower levels of education. This finding is consis-
tent with previous studies in other populations which demonstrated that both income [15, 31,
32] and education [33] level have a significant impact on QOL: the lower, the worse. It may be
hypothesized that higher socio-economic and educational level of patients may lead to better
access to information and health services; as a result, these individuals may have fewer prob-
lems and feel less uncertain.
Certain limitations of the current study should be considered. First, the sample of women with
BC symptoms was obtained from only one area in Indonesia, West Java, that might not be a rep-
resentative for the whole Indonesian archipelago. Second, the participants of the present study
were women with BC symptoms who visited the hospital. It could be argued that these women
were anxious enough about the symptoms they observed to enable them to visit the hospital, com-
pared to the women who did not visit the hospital although they probably observed some BC
symptoms. This might have biased the results. Third, the comparison group consisting of adult
women from the general population, was not screened for the presence of any diseases. Therefore,
it is possible that this group included a few participants with BC symptoms, a BC diagnosis, or BC
survivors. This might have influenced the results, leading to an underestimation of the actual dif-
ferences between the groups. Fourth, the choice of generic instruments: WHQOL-BREF and EQ-
5D-5L, might be not sensitive enough to measure the QOL and health status of the patients com-
pared to disease-specific instruments such as the European Organization for Research and Treat-
ment of Cancer QOL Questionnaire-C30 (EORTC QLQ-C30) [34] and the Functional
Assessment of Cancer Therapy-General (FACT-G) [35]. However, since the aim of the present
study was to compare QOL of women with BC symptoms to women from the general population,
which are less likely to have any BC symptoms, generic QOL instruments were considered as the
best tool to serve this aim. Nevertheless, there are significant differences between the groups,
which indicate worse QOL and health status in the group with BC symptoms. Fifth, although the
EQ-5D-5L had been validated and used in breast cancer patients’ population in different countries
across the world [25], this was not the case for Indonesia. So, it is not known for certain that the
psychometric properties are supported accurately in the context of this study.
Future research might investigate other factors that may contribute to the QOL of women
with BC symptoms, such as social support or physical activities, and find and evaluate effective
ways to promote and improve their QOL. Studies might evaluate strategies carried out by
healthcare providers and professionals, e.g., physicians, nurses, psychologists, or community
health workers to increase their compliance and reduce physical and psychological problems,
such as provision of individualized information, symptom management, counseling, or psy-
chosocial interventions.
Conclusions
Our study showed that Indonesian women with BC symptoms before the definitive diagnosis
reported lower physical and psychological QOL and more pain/discomfort and anxiety/
depression compared to the Indonesian women in general. Awareness and support for them
from the medical field might improve these aspects of QOL.
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